Scarica l'app Stockscreener
2.69
2.68%
0.08
Precedente Chiudi:
$2.61
Aprire:
$2.62
Volume 24 ore:
584.51K
Relative Volume:
0.23
Capitalizzazione di mercato:
$22.97M
Reddito:
$356.60K
Utile/perdita netta:
$-25.97M
Rapporto P/E:
-3.6136
EPS:
-0.7444
Flusso di cassa netto:
$-25.22M
1 W Prestazione:
+2.68%
1M Prestazione:
+19.64%
6M Prestazione:
+66.46%
1 anno Prestazione:
-65.64%
Intervallo 1D:
$2.59
$2.74
Intervallo di 1 settimana:
$2.37
$3.12
Portata 52W:
$1.0901
$11.18
Geovax Labs Inc Stock (GOVX) Company Profile
Nome
Geovax Labs Inc
Settore
Industria
Telefono
678-384-7220
Indirizzo
1900 LAKE PARK DRIVE, SMYRNA
Confronta GOVX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| GOVX | 2.70 | 22.97M | 356.60K | -25.97M | -25.22M | -0.7444 |
| VRTX | 449.94 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.83 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.38 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.56 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.25 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-16 | Iniziato | ROTH MKM | Buy |
| 2020-11-19 | Iniziato | Maxim Group | Buy |
Geovax Labs Inc Borsa (GOVX) Ultime notizie
Alliance Global Partners Initiates Coverage of GeoVax Labs (GOVX) with Buy Recommendation - MSN
GeoVax Announces Positive Interim Data Review for Phase 2 - GlobeNewswire
GeoVax regains compliance with Nasdaq listing standards By Investing.com - Investing.com Australia
GeoVax regains compliance with Nasdaq listing standards - Investing.com India
GeoVax reports progress in CLL vaccine booster trial - Investing.com India
GeoVax reports progress in CLL vaccine booster trial By Investing.com - Investing.com Canada
GeoVax Labs announces interim data from Phase 2 trial of Vaccine technology - TipRanks
GeoVax's COVID Booster Shows Promise in Leukemia Patients, Outperforms mRNA Vaccine | GOVX Stock News - StockTitan
Analysts Set Expectations for GeoVax Labs FY2024 Earnings - Defense World
Earnings call: GeoVax reports progress in vaccine trials, financial updates By Investing.com - Investing.com Australia
Brokerages Set GeoVax Labs, Inc. (NASDAQ:GOVX) PT at $12.67 - Defense World
GeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2024 Earnings Call Transcript - MSN
Earnings call: GeoVax reports progress in vaccine trials, financial updates - Investing.com
U.S. Stock market top losers: Gaucho Group Holdings sees decline of 55.06% while GeoVax Labs looses 23.53% in early trading - Business Upturn
Alliance Global Partners Initiates Coverage on GeoVax Labs (NASDAQ:GOVX) - Defense World
Geovax Labs Inc (GOVX) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges - Yahoo Finance
GeoVax Labs Reports Improved Earnings and Strategic Progress - TipRanks
GeoVax Labs reports Q3 EPS (91c), consensus ($1.48) - TipRanks
GeoVax Reports Progress on COVID-19 Vaccine and Cancer Therapies in Q3 2024 Financial Results - Citybuzz
GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GeoVax Q3 Loss Narrows to $5.8M as BARDA Contract Boosts Revenue to $2.8M | GOVX Stock News - StockTitan
GeoVax Labs initiated with a Buy at Alliance Global Partners - Yahoo Finance
This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday - Benzinga
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 - GlobeNewswire
Should You Buy GeoVax Labs Inc. (GOVX) After Golden Cross? - MSN
GeoVax expands offering size to $30 million By Investing.com - Investing.com Australia
GeoVax expands offering size to $30 million - Investing.com India
Geovax Labs (STU:E8LA) Intrinsic Value: Projected FCF : €-111.10 (As of Oct. 16, 2024) - GuruFocus.com
GeoVax postpones stockholder meeting due to low turnout - Investing.com
GeoVax postpones stockholder meeting due to low turnout By Investing.com - Investing.com UK
GeoVax stock rockets 50% on BARDA award for COVID-19 vaccine - MSN
InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying - MSN
Market Insight: Geovax Labs Inc (GOVX)’s Notable Drop, Closing at 2.03 - The Dwinnex
Geovax Labs Inc (GOVX)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Buying Buzz: Geovax Labs Inc [GOVX] President, CEO DODD DAVID A purchases 8,000 shares of the company - Knox Daily
GOVX’s 52-Week Rollercoaster: From $1.09 to $11.18 – What’s Next for Investors? - The InvestChronicle
Geovax Labs Inc (GOVX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... - Yahoo Finance
Geovax Labs Inc (GOVX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ... By GuruFocus - Investing.com Canada
Views of Wall Street’s Leading Experts on Geovax Labs Inc - SETE News
Investing in Geovax Labs Inc (GOVX) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Keeping an Eye on Geovax Labs Inc (GOVX) After Insider Trading Activity - Knox Daily
GeoVax Labs reports quorum shortfall, delays Special Meeting By Investing.com - Investing.com Australia
GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - The Manila Times
Closing Figures: Geovax Labs Inc (GOVX)’s Negative Finish at 2.20, Down -8.71 - The Dwinnex
GeoVax Labs reports quorum shortfall, delays Special Meeting - Investing.com India
Geovax Labs Inc [NASDAQ: GOVX] Sees Decrease in Stock Value - Knox Daily
GeoVax Labs inks sales agreement, may offer stock By Investing.com - Investing.com Canada
GeoVax Labs inks sales agreement, may offer stock - Investing.com India
Geovax Labs Inc Azioni (GOVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Geovax Labs Inc Azioni (GOVX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DODD DAVID A | President, CEO |
Feb 22 '24 |
Buy |
2.27 |
8,209 |
18,663 |
18,661 |
| DODD DAVID A | President, CEO |
Feb 21 '24 |
Buy |
2.15 |
520 |
1,118 |
10,452 |
| Reynolds Mark | CFO |
Feb 07 '24 |
Buy |
2.77 |
2,000 |
5,540 |
7,213 |
| McKee Kelly T. Jr. | Chief Medical Officer |
Dec 22 '23 |
Buy |
0.36 |
6,944 |
2,500 |
35,782 |
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):